港股异动丨中富资源(0274.HK)复牌暴涨逾126% 终止配股
格隆汇4月23日丨中富资源(0274.HK)复牌暴涨逾126%,报0.217港元,高见0.25港元创去年7月以来新高,总市值2.74亿港元。中富资源昨日公布,于2021年3月1日,公司作为发行方与一名独立第三方作为认购方订立了认购协议。根据认购协议,公司拟向认购方有条件发行及配发公司新股份以筹集2.016亿港元。监于认购方的财务状况变动及长时间停牌情况,公司及认购方已同意终止认购协议。因此,公司与认购方于2021年4月22日订立了终止协议。

Follow us
Find us on
Facebook,
Twitter ,
Instagram, and
YouTube or frequent updates on all things investing.Have a financial topic you would like to discuss? Head over to the
uSMART Community to share your thoughts and insights about the market! Click the picture below to download and explore uSMART app!

Disclaimers
uSmart Securities Limited (“uSmart”) is based on its internal research and public third party information in preparation of this article. Although uSmart uses its best endeavours to ensure the content of this article is accurate, uSmart does not guarantee the accuracy, timeliness or completeness of the information of this article and is not responsible for any views/opinions/comments in this article. Opinions, forecasts and estimations reflect uSmart’s assessment as of the date of this article and are subject to change. uSmart has no obligation to notify you or anyone of any such changes. You must make independent analysis and judgment on any matters involved in this article. uSmart and any directors, officers, employees or agents of uSmart will not be liable for any loss or damage suffered by any person in reliance on any representation or omission in the content of this article. The content of the article is for reference only and does not constitute any offer, solicitation, recommendation, opinion or guarantee of any securities, virtual assets, financial products or instruments. Regulatory authorities may restrict the trading of virtual asset-related ETFs to only investors who meet specified requirements. Any calculations or images in the article are for illustrative purposes only.
Investment involves risks and the value and income from securities may rise or fall. Past performance is not indicative of future performance. Please carefully consider your personal risk tolerance, and consult independent professional advice if necessary.